Head to Head Analysis: Baxter International (NYSE:BAX) versus LogicMark (OTCMKTS:LGMKD)

LogicMark (OTCMKTS:LGMKD) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, dividends, institutional ownership, valuation, risk, analyst recommendations and earnings.

Valuation and Earnings

This table compares LogicMark and Baxter International”s revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
LogicMark	$9.90 million	0.12	-$9.00 million	($94.52)	-0.01
Baxter International	$11.24 billion	1.16	-$957.00 million	($2.07)	-12.23

LogicMark has higher earnings, but lower revenue than Baxter International. Baxter International is trading at a lower price-to-earnings ratio than LogicMark, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares LogicMark and Baxter International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
LogicMark	-90.21%	-57.08%	-44.90%
Baxter International	-9.27%	16.57%	5.24%

Volatility and Risk

LogicMark has a beta of 1.67, suggesting that its share price is 67% more volatile than the S&P 500. Comparatively, Baxter International has a beta of 0.65, suggesting that its share price is 35% less volatile than the S&P 500.

Insider & Institutional Ownership

7.9% of LogicMark shares are held by institutional investors. Comparatively, 90.2% of Baxter International shares are held by institutional investors. 2.2% of LogicMark shares are held by insiders. Comparatively, 0.2% of Baxter International shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Analyst Ratings

This is a breakdown of current recommendations and price targets for LogicMark and Baxter International, as provided by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
LogicMark	0	1	0	0	2.00
Baxter International	3	10	1	0	1.86

Baxter International has a consensus target price of $21.73, indicating a potential downside of 14.19%. Given Baxter International’s higher possible upside, analysts clearly believe Baxter International is more favorable than LogicMark.

Summary

Baxter International beats LogicMark on 9 of the 14 factors compared between the two stocks.

About LogicMark

LogicMark, Inc. provides personal emergency response systems (PERS), health communications devices, and Internet of Things (IoT) technology that creates a connected care platform in the United States. The company’s devices provide people with the ability to receive care at home and age independently and to check, manage, and monitor a loved one’s health and safety remotely. It also manufactures and distributes non-monitored and monitored personal emergency response systems, which are offered through the United States Veterans Health Administration (VHA), direct-to-consumers, healthcare durable medical equipment dealers and distributors, monitored security dealers and distributors, and its ecommerce website logicmark.com and Amazon.com. The company was formerly known as Nxt-ID, Inc. and changed its name to LogicMark, Inc. in March 2022. LogicMark, Inc. was founded in 2006 and is based in Louisville, Kentucky.

About Baxter International

Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company operates through four segments: Medical Products and Therapies, Healthcare Systems and Technologies, Pharmaceuticals, and Kidney Care. The company offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space, including surgical video technologies, precision positioning devices, and other accessories. It also provides administrative sets; adhesion prevention products; inhaled anesthesia; drug compounding; chronic and acute dialysis therapies and services, including peritoneal dialysis (PD), hemodialysis (HD), continuous renal replacement therapies (CRRT), and other organ support therapies. The company’s products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, and patients at home under physician supervision. The company sells its products through direct sales force, as well as through independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic products; and a collaborative research agreement with Miromatrix Medical Inc. aiming to advance care for patients with acute liver failure. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.